Novartis
NVS
$98.91
Share price
1.85%
Change (1 day)
10.16%
Change (1 year)
Categories
Novartis AG is a biotechnology and pharmaceutical company based in Basel, Switzerland. Novartis was formed in 1996 from a merger of the two Basel pharmaceutical and chemical companies Ciba-Geigy AG and Sandoz AG. Novartis is one of the largest pharmaceutical companies in the world with sales of USD 47.4 billion in 2019.
Novartis (NVS) - Cash on Hand
Cash on Hand as of March 2023 : $12.26 B
According to Novartis's latest financial reports the company has $12.26 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Novartis - Cash on Hand chart (from 2001 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $18.61 B | -33.79% |
| 2021-12-31 | $28.11 B | 148.94% |
| 2020-12-31 | $11.29 B | -1.34% |
| 2019-12-31 | $11.44 B | -28.3% |
| 2018-12-31 | $15.96 B | 68.31% |
| 2017-12-31 | $9.48 B | 21.96% |
| 2016-12-31 | $7.77 B | 42.78% |
| 2015-12-31 | $5.44 B | -60.71% |
| 2014-12-31 | $13.86 B | 50.31% |
| 2013-12-31 | $9.22 B | 13.59% |
| 2012-12-31 | $8.11 B | 59.98% |
| 2011-12-31 | $5.07 B | -37.61% |
| 2010-12-31 | $8.13 B | -53.38% |
| 2009-12-31 | $17.44 B | 185.25% |
| 2008-12-31 | $6.11 B | -53.66% |
| 2007-12-31 | $13.20 B | 65.95% |
| 2006-12-31 | $7.95 B | -27.24% |
| 2005-12-31 | $10.93 B | -25.08% |
| 2004-12-31 | $14.59 B | 10.06% |
| 2003-12-31 | $13.25 B | 5.44% |
| 2002-12-31 | $12.57 B | -4.61% |
| 2001-12-31 | $13.18 B |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $23.51 B | 91.84% | 🇺🇸 USA |
 Pfizer PFE | $22.73 B | 85.42% | 🇺🇸 USA |
 Abbott Laboratories ABT | $10.17 B | -17.05% | 🇺🇸 USA |
 Sanofi SNY | $14.35 B | 17.06% | 🇫🇷 France |
 Merck MRK | $13.19 B | 7.60% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $8.99 B | -26.63% | 🇺🇸 USA |
 AstraZeneca AZN | $6.46 B | -47.29% | 🇬🇧 UK |
 GlaxoSmithKline GSK | $8.64 B | -29.53% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | $2.80 B | -77.15% | 🇮🇱 Israel |